Brief: Neogenomics Inc - Pantracer Lbx Test Receives Medicare Coverage Under CMS Moldx Program
16/03/2026 11:41
March 16 (Reuters) - Neogenomics Inc NEO.O: NEOGENOMICS INC - PANTRACER LBX TEST RECEIVES MEDICARE COVERAGE UNDER CMS MOLDX PROGRAM Source text: ID:nBw1tXGVma Further company coverage: NEO.O ((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on NeoGenomics
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
NeoGenomics rises after BTIG upgrades to 'buy'
Brief: Neogenomics Announces Executive Leadership And Board Of Directors Succession Plan
Brief: Neogenomics Receives Medicare Coverage For Radar St For Immunotherapy Treatment Response Monitoring